Correction to: Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries (BioDrugs, (2024), 38, 1, (133-144), 10.1007/s40259-023-00636-z)

Hyunjung Woo, Gyeongseon Shin, Donghwan Lee, Hye Young Kwon, Seung Jin Bae

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Correction to: Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries (BioDrugs, (2024), 38, 1, (133-144), 10.1007/s40259-023-00636-z)'. Together they form a unique fingerprint.

Nursing and Health Professions

Social Sciences

Agricultural and Biological Sciences